Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-06

Clinical Trial Update: Induced Hypertension for Treatment of Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating induced hypertension for treating delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Cerebral Ischemia, Subarachnoid Hemorrhage | Phase 3 | Status: TERMINATED